For more information, contact:
This is part of an ongoing series which will feature one company every week that received the MetroConnect Prize, presented by JPMorgan Chase
The digital health industry is on the brink of rapid growth.
One in five people in the world now own a smartphone. By 2016, the number of smartphone users worldwide will surpass 2 billion. Although most people are familiar with using smart phones to text message, check emails, or play games, the ubiquity of smartphone technology has allowed for transformative advances in many fields, not the least in healthcare and medicine.
Entra Health, a San Diego-based mobile health IT company, capitalizes on smartphone technology to bring to patients and healthcare providers a system to monitor and communicate about patients’ health.
“We provide a suite of technology solutions and services,” said Richard C. Strobridge, CEO and co-founder of Entra Health, “[Our services] range from our own FDA Class II software platform through to our comprehensive one-stop shopping for remote patient monitoring, telemedicine and mobile health devices.”
Entra Health integrates wireless technology with healthcare needs. The company’s expertise in worldwide medical device regulations have also propelled their devices into an international standard.
“Foreign markets have always posed a unique strategic advantage for Entra Health,” said Strobridge. “Our strategy from the beginning was to get as many international regulatory approvals for our medical device product as possible. This strategy has allowed us to become the de facto glucose meter for clinical trials worldwide.”
With the MetroConnect prize, Entra Health used the funds for sales development, regulatory submissions, patent development, and travel to develop business partnerships in South Korea, China, Australia, and Germany.
“We plan to continue with our strategy of strengthening our intellectual property position, complete platform licensing strategy in Australia, and complete regulatory submissions […] in Australia, Europe, and Mexico,” said Strobridge. “The MetroConnect prize has given us an added sense of pride and affirmation of Entra Health's core mission of keeping people healthier while decreasing the financial burden of chronic disease.”
The success of small- and medium-sized businesses is critical to the region’s future, and increasing their global reach is crucial to that success. Through the MetroConnect Prize, companies such as Entra Health received $10,000 grants to assist with their next step in going global.
Subscribe here to receive new posts on this topic